Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Hongqing Zhuang, Zhiyong Yuan, Jun Wang, Qingsong Pang, Lujun Zhao & Ping Wang. (2014) Preliminary analysis of the risk factors for radiation pneumonitis in patients with non-small-cell lung cancer treated with concurrent erlotinib and thoracic radiotherapy. OncoTargets and Therapy 7, pages 807-813.
Read now
Read now
Gerhard Hamilton & Ulrike Olszewski. (2013)
Picoplatin pharmacokinetics and chemotherapy of non-small cell lung cancer. Expert Opinion on Drug Metabolism & Toxicology 9:10, pages 1381-1390.
Read now
Read now
Alex Kudrin. (2012) Overview of cancer vaccines. Human Vaccines & Immunotherapeutics 8:9, pages 1335-1353.
Read now
Read now
Shengxiang Ren, Songwen Zhou, Ling Zhang, Jianfang Xu, Meijun Lv, Jie Zhang, Caicun Zhou & Jie Zhang. (2010) High-Level mRNA of Excision Repair Cross-Complementation Group 1 Gene Is Associated With Poor Outcome of Platinum-Based Doublet Chemotherapy of Advanced Nonsmall Cell Lung Cancer Patients. Cancer Investigation 28:10, pages 1078-1083.
Read now
Read now
Articles from other publishers (13)
Ahmad Ari Shodikin, Mutalazimah Mutalazimah, Muwakhidah Muwakhidah & Nur Lathifah Mardiyati. (2023) TINGKAT PENDIDIKAN IBU DAN POLA ASUH GIZI HUBUNGANNYA DENGAN KEJADIAN STUNTING PADA BALITA USIA 24-59 BULAN. Journal of Nutrition College 12:1, pages 33-41.
Crossref
Crossref
Kamya Goyal, Bharti Mangla, Navdeep Singh, Honey Goel, Kunal Goyal, Shammy Jindal, Mohammad Javed Ansari & Waleed H. Almalki. 2022. Nanotherapeutics in Cancer Vaccination and Challenges. Nanotherapeutics in Cancer Vaccination and Challenges
325
348
.
Brian N. Arnold & Anthony W. Kim. 2018. Lung Cancer: A Practical Approach to Evidence-Based Clinical Evaluation and Management. Lung Cancer: A Practical Approach to Evidence-Based Clinical Evaluation and Management
67
81
.
Yuan Hu, Yin Hong, YuanJie Xu, Ping Liu, Dai-Hong Guo & Yibang Chen. (2014) Inhibition of the JAK/STAT pathway with ruxolitinib overcomes cisplatin resistance in non-small-cell lung cancer NSCLC. Apoptosis 19:11, pages 1627-1636.
Crossref
Crossref
Ritsuko KomakiHeath D SkinnerRitsuko Komaki. 2013. Personalized Management of Lung Cancer. Personalized Management of Lung Cancer
76
86
.
John A. Howington, Matthew G. Blum, Andrew C. Chang, Alex A. Balekian & Sudish C. Murthy. (2013) Treatment of Stage I and II Non-small Cell Lung Cancer. Chest 143:5, pages e278S-e313S.
Crossref
Crossref
Connie G. Chiu, Simon K. Chan, Z. Amy Fang, Hamid Masoudi, Richard Wood-Baker, Steven J.M. Jones, Blake Gilks, Janessa Laskin & Sam M. Wiseman. (2012) Beta-catenin expression is prognostic of improved non–small cell lung cancer survival. The American Journal of Surgery 203:5, pages 654-659.
Crossref
Crossref
Tamás F Molnár, Zoltan Balikó, Veronika Sárosi & Peter Örs Horváth. (2010) Survival after Surgery following Chemotherapy for Non-Small-Cell Lung Cancer. Asian Cardiovascular and Thoracic Annals 18:2, pages 141-146.
Crossref
Crossref
Paul E. Van Schil, Mich?le De Waele, Jeroen M. Hendriks & Patrick R. Lauwers. (2009) Surgical treatment of stage III non-small cell lung cancer. European Journal of Cancer 45, pages 106-112.
Crossref
Crossref
Junji Yoshida, Kanji Nagai, Hisao Asamura, Tomoyuki Goya, Yoshihiko Koshiishi, Yasunori Sohara, Kenji Eguchi, Masaki Mori, Yohichi Nakanishi, Ryosuke Tsuchiya & Etsuo Miyaoka. (2009) Visceral Pleura Invasion Impact on Non-small Cell Lung Cancer Patient Survival: Its Implications for the Forthcoming TNM Staging Based on a Large-Scale Nation-Wide Database. Journal of Thoracic Oncology 4:8, pages 959-963.
Crossref
Crossref
Ilene Browner & Michael Purtell. (2009) Chemotherapy in the Older Patient with Operable Non?Small Cell Lung Cancer: Neoadjuvant and Adjuvant Regimens. Thoracic Surgery Clinics 19:3, pages 377-389.
Crossref
Crossref
Jeffrey A. Borgia, Sanjib Basu, L Penfield Faber, Anthony W. Kim, John S. Coon, Kelly A. Kaiser-Walters, Cristina Fhied, Sherene Thomas, Omid Rouhi, William H. Warren, Philip Bonomi & Michael J. Liptay. (2009) Establishment of a Multi-Analyte Serum Biomarker Panel to Identify Lymph Node Metastases in Non-small Cell Lung Cancer. Journal of Thoracic Oncology 4:3, pages 338-347.
Crossref
Crossref
Fabio Puglisi, Giuseppe Aprile & Gianpiero Fasola. (2008) Hot topics and landmark studies from the 43rd annual meeting of the American Society of Clinical Oncology. Anti-Cancer Drugs 19:2, pages 221-233.
Crossref
Crossref